PROVIDER PROFILE · NPI 1669545802

Thomas ReskeMD

Hematology-OncologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

122

Distinct HCPCS

Medicare payment

$7K

Peer benchmark

Total Medicare services vs. 360 Hematology-Oncology providers in MA — bottom quintile (cohort median 624).

PRESCRIBING · PART D · 2024

Total Rx claims

1,700

Beneficiaries

—

Total drug cost

$236K

Distinct drugs

Brand share

18.2%

Top prescribed drugs

Apixaban153 claims

Levothyroxine Sodium127 claims

Atorvastatin Calcium91 claims

Metoprolol Succinate85 claims

Quetiapine Fumarate80 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$498

Payment records

By payment type

Food and Beverage$498

REFERRAL NETWORK

Where Thomas Reske's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Brian Boulmay Hematology-Oncology · New Orleans, LA	45	361
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	32	95
Raman Danrad Diagnostic Radiology · New Orleans, LA	14	25

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history